ASCO 2022 Conference Coverage

 

ASCO 2022 Conference Coverage
R

Lecture Summary - ASCO 2022 Updates on the Evolution of Asparaginase in the Management of ALL

By ASCO 2022 Conference Coverage FEATURING Ryan Cassaday
By ASCO 2022 Conference Coverage FEATURING Ryan Cassaday
0 views
June 28, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

03:57
Lilly Medical Affairs

Resistance Mechanisms to ET, Including ESR1 Mutations in HR+, HER2- …

Feat. K. Jhaveri

Featured Video

03:38
Lilly Medical Affairs

SERDS: Relevance and Role in Current & Future Treatments for HR+…

Feat. K. Jhaveri
Leukemia
47
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Efficacy & Safety Results From the P…

Feat. J. Cortés
11:45
ASCO 2022 Conference Coverage

ASCO 2022 Efficacy & Safety Results From the Phase 3 ASCEMBL Stu…

Feat. J. Cortés
02:16
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on Overall Survival by IDH2 Mutant Allel…

Feat. S. De Botton
08:40
ASCO 2022 Conference Coverage

ASCO 2022 on Overall Survival by IDH2 Mutant Allele (R140 or R172) i…

Feat. S. De Botton
07:21
ASCO 2022 Conference Coverage

ASCO 2022 Updated Results From a Phase II Study of mini-HCVD + Ino +…

Feat. W. Macaron
06:33
ASCO 2022 Conference Coverage

ASCO 2022 Treatment-Free Remission in CML Patients Following the Dis…

Feat. F. Haddad
36
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Treatment-Free Remission in CML Patients…

Feat. F. Haddad
56
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Updates on the Evolution of Asparaginase…

Feat. R. Cassaday
06:42
ASCO 2022 Conference Coverage

ASCO 2022 Updates on the Evolution of Asparaginase in the Management…

Feat. R. Cassaday
01:53
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on Leveraging AML Genomics Across the Th…

Feat. G. Mannis
03:47
ASCO 2022 Conference Coverage

ASCO 2022 on a Phase 1b Study of Blinatumomab With the Anti-Programm…

Feat. C. Papayannidis
55
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on a Phase 1b Study of Blinatumomab With…

Feat. C. Papayannidis
06:50
ASCO 2022 Conference Coverage

ASCO 2022 on a Phase II Study of Hyper-CVAD With Sequential Blina +/…

Feat. N. Short
01:09
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on a Phase II Study of Hyper-CVAD With S…

Feat. N. Short
03:56
ASCO 2022 Conference Coverage

ASCO 2022 Bosutinib in Newly Diagnosed CML: Gastrointestinal, Liver,…

Feat. J. Cortés
36
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Bosutinib in Newly Diagnosed CML: Gastro…

Feat. J. Cortés
06:30
ASCO 2022 Conference Coverage

ASCO 2022 Efficacy and Safety of Bosutinib in Later-Line Patients Wi…

Feat. C. Gambacorti-Passerini